Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

WorldHeart to begin rotary VAD trial

This article was originally published in The Gray Sheet

Executive Summary

WorldHeart announced Feb. 15 that it has received approval from the Greek Ministry of Health to begin clinical trials of its second-generation rotary ventricular assist device. WorldHeart acquired the continuous flow pump technology in February 2005 with the purchase of Medquest. The firm says that the VAD initially will be indicated as a bridge to transplant but will eventually be expanded for use as a destination therapy. Thoratec's HeartMate is the only device with FDA approval for permanent support of heart failure patients who are ineligible for transplant...
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

MT023252

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel